NCT03678493View on ClinicalTrials.gov

A Study of FMT in Patients With AML Allo HSCT in Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

February 11, 2022

Study Completion Date

December 4, 2023

Conditions
Acute Myeloid LeukemiaAllogeneic Hematopoietic Cell Transplantation
Interventions
BIOLOGICAL

Fecal Microbiota Transplant (FMT)

Oral Capsule

OTHER

Placebo

Oral Capsule

Trial Locations (1)

55455

Masonic Cancer Center at University of Minnesota, Minneapolis

All Listed Sponsors
lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT03678493 - A Study of FMT in Patients With AML Allo HSCT in Recipients | Biotech Hunter | Biotech Hunter